New Indication for Plavix (Clopidogrel) Now Approved in the European Union
February 9, 2021 February 9, 2021 — The European Commission has approved an additional indication for Plavix ® (clopidogrel) to include its use in combination with aspirin in adult patients with moderate to high-risk Transient Ischemic Attack (TIA) (ABCD2 score ≥4) or minor Ischemic Stroke (IS) (NIHSS 1 ≤3) within 24 hours of either the TIA or IS event. 2 Usage under this new indication can continue for 21 days, followed by long-term single anti-platelet therapy. The additional indication is based on the results of two double-blind, randomized, placebo-controlled investigator-initi...
Source: cathlabdigest.com